Nurofen Plus (codeine/ibuprofen) - Important Safety Information from Reckitt Ireland Ltd. as approved by the HPRA (21.10.22)

Notice type: 3rd Party Publications

Date: 24/10/2022




Problem Or Issue:

Important Safety Information from Reckitt Ireland Ltd. regarding Nurofen Plus (codeine/ibuprofen): Serious clinical harms, including renal tubular acidosis and severe hypokalaemia, following prolonged use of codeine/ibuprofen at higher than recommended doses due to codeine dependence


Important Safety Information – Nurofen Plus (codeine-ibuprofen)


« Back